Ocular Therapeutix (OCUL) director Lindstrom received 14,000 shares

Insider transactions reported

Lindstrom Richard L Md (director at Ocular Therapeutix Inc., OCUL) reported that they received 14,000 shares on Jun 10, 2026. After these transactions the filing shows 260,933 shares held directly.

Reporting person

Lindstrom Richard L Md

Options and other derivatives

Holdings before and after

• Common Stock: 246,933 to 260,933 direct
• Stock Option (Right to Buy): 0 to 44,000 direct

Footnotes from the filing

1. 1. On June 10, 2026, the reporting person was granted restricted stock units ( RSUs ) under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the Company ). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.
2. 2. Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.

Transaction codes in this filing

Grant or award:

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ